Date Filed | Type | Description |
10/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
08/22/2023 |
SC 13G/A
| Archon Capital Management LLC reports a 10% stake in Neuronetics, Inc. |
08/18/2023 |
SC 13D/A
| Cannell Capital reports a 8.4% stake in Neuronetics, Inc. |
08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/08/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
08/08/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/09/2023 |
SC 13D/A
| Cannell Capital reports a 10% stake in Neuronetics, Inc. |
05/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/09/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
05/09/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
04/13/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/13/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
03/22/2023 |
SC 13D/A
| Cannell Capital reports a 11% stake in Neuronetics, Inc. |
03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
03/07/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/07/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
03/07/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
02/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2023 |
SC 13G
| SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC/ DE reports a 3.3% stake in Neuronetics Inc |
01/09/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
12/29/2022 |
8-K
| Quarterly results |
11/15/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/09/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
|